Accessibility settings

This paper is in the following e-collection/theme issue:

Systematic Review Protocols (765) Public (e)Health, Digital Epidemiology and Public Health Informatics (2380) Prevention and Health Promotion (2310) Pharmacovigilance (254) Immunology, Allergy, Rheumatology (204) Infectious Diseases (non-STD/STI) (1951) Vaccination and Immunization in the Digital Age (517) Pregnancy Information, Education and Lifestyle Interventions (487)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/94382, first published .
Pediatrician examines baby with stethoscope, teddy bear nearby

Efficacy, Effectiveness, and Immunogenicity of the Respiratory Syncytial Virus Prefusion F Vaccine Administered During Pregnancy: Protocol for a Living Systematic Review and Meta-Analysis

Efficacy, Effectiveness, and Immunogenicity of the Respiratory Syncytial Virus Prefusion F Vaccine Administered During Pregnancy: Protocol for a Living Systematic Review and Meta-Analysis

Authors of this article:

Agustina Mazzoni1 Author Orcid Image ;   Ariel Bardach1 Author Orcid Image ;   Mabel Berrueta1 Author Orcid Image ;   Agustin Ciapponi1 Author Orcid Image ;   Karen Klein1 Author Orcid Image ;   Martin Brizuela1 Author Orcid Image ;   Carolina Nigri1 Author Orcid Image ;   Noelia Castellana1 Author Orcid Image ;   Jamile Ballivian1 Author Orcid Image ;   Juan Manuel Sambade1 Author Orcid Image ;   Katharina Stegelmann1 Author Orcid Image ;   Divya Patel2 Author Orcid Image ;   Jessica E Atwell3 Author Orcid Image ;   Jennifer Deese2 Author Orcid Image ;   Sarah N Cox2 Author Orcid Image ;   Lu Wang4 Author Orcid Image ;   Xu Xiong5 Author Orcid Image ;   Andy Stergachis6 Author Orcid Image ;   Flor M Munoz7 Author Orcid Image ;   Pierre Buekens5 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Agustina Mazzoni   1 , MD ;   Ariel Bardach   1 , PhD ;   Mabel Berrueta   1 , MD ;   Agustin Ciapponi   1 , PhD ;   Karen Klein   1 , MD ;   Martin Brizuela   1 , MD ;   Carolina Nigri   1 , BSc ;   Noelia Castellana   1 , BSc ;   Jamile Ballivian   1 , MD ;   Juan Manuel Sambade   1 , MD ;   Katharina Stegelmann   1 , MMedSc ;   Divya Patel   2 , MS ;   Jessica E Atwell   3 , PhD ;   Jennifer Deese   2 , PhD ;   Sarah N Cox   2 , PhD ;   Lu Wang   4 , PhD ;   Xu Xiong   5 , MD ;   Andy Stergachis   6 , PhD ;   Flor M Munoz   7 , MD ;   Pierre Buekens   5 , PhD

1 Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina

2 Medical Evidence Development, Research & Development, Pfizer, Inc., New York, NY, United States

3 Maternal Immunization Team, Global Medical Affairs, Pfizer (United States), New York, NY, United States

4 Statistical Research and Data Science Center, Data Sciences and Analytics, Pfizer, Inc., New York, NY, United States

5 Department of Epidemiology, Celia Scott Weatherhead School of Public Health, Tulane University, New Orleans, LA, United States

6 Departments of Pharmacy and Global Health, University of Washington, Seattle, WA, United States

7 Departments of Pediatrics and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States

Corresponding Author:

  • Agustina Mazzoni, MD
  • Institute for Clinical Effectiveness and Health Policy (IECS)
  • Lavalleja 856
  • Buenos Aires C1414DTR
  • Argentina
  • Phone: 54 0111558570687
  • Email: amazzoni@iecs.org.ar